Literature DB >> 15568451

Human immunodeficiency virus and tuberculosis co-infection in Saudi Arabia.

A A Alrajhi1, A Nematallah, S Abdulwahab, Z Bukhary.   

Abstract

Our study determined the rate of screening tuberculosis patients for HIV co-infection and the HIV seroprevalence among them. We retrospectively reviewed medical charts of 437 patients diagnosed with tuberculosis from 1995-2000 in Riyadh, Saudi Arabia. Screening was done for 178 (41%) patients: 2 (1.1%) of these were found to be HIV positive. Prior to screening, 4 patients were already known to be HIV positive. Males were screened more often than females (45% and 36% respectively). All HIV positive patients were males. Screening was not affected by origin of the patient, history of prior tuberculosis or treatment, type of tuberculosis involvement or resistance to first line anti-tuberculosis agents. In Saudi Arabia, screening for HIV in tuberculosis patients remains underutilized. Among screened patients, seropositivity was low.

Entities:  

Mesh:

Year:  2002        PMID: 15568451

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  HIV in the Kingdom of Saudi Arabia: Can We Change the Way We Deal with Co-Infections.

Authors:  Maha Al-Mozaini; Tahani Alrahbeni; Qais Dirar; Jawaher Alotibi; Abdulrahman Alrajhi
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

2.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

3.  De Novo intracerebral aneurysm in a child with acquired immunodeficiency syndrome.

Authors:  Mahmood D Al-Mendalawi; Saleh S Baeesa
Journal:  Neurosciences (Riyadh)       Date:  2016-01       Impact factor: 0.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.